Thermo Scientific Orbitrap Exploris MX Mass Detector

Overview

The Thermo Scientific Orbitrap Exploris MX Mass Detector is a dedicated high-resolution accurate-mass (HRAM) detection platform engineered for routine quality control (QC) and release testing in biopharmaceutical manufacturing environments. Built upon the proven Orbitrap mass analyzer architecture—based on electrostatic trapping and image current detection—it delivers consistent, reproducible mass measurement performance without compromising robustness or operational simplicity. Unlike research-grade instruments optimized for discovery workflows, the Exploris MX is purpose-built for GMP-aligned laboratories requiring long-term mass stability, minimal operator intervention, and seamless integration into regulated chromatographic data systems. Its core function is to provide definitive mass confirmation across a broad dynamic range—from small-molecule excipients and process impurities to intact monoclonal antibodies (mAbs), reduced heavy/light chains, denatured or native subunits, glycoforms, and oligonucleotide therapeutics—including their sequence variants and degradation products.

Key Features

• Orbitrap mass analyzer with electrostatic field trapping and Fourier-transform-based signal processing, enabling high-fidelity spectral acquisition at up to 180,000 resolution (FWHM at m/z 200)
• Dedicated QC firmware and streamlined instrument control interface—reducing method setup time and minimizing training requirements for QC analysts
• Integrated EASY-IC (Electron-Activated Yttrium-Stabilized Zirconia Internal Calibration) system for continuous real-time mass recalibration, achieving <1 ppm RMS mass drift over ≥5 days without manual intervention
• Robust ion transmission pathway optimized for LC-MS coupling, supporting both electrospray ionization (ESI) and heated electrospray ionization (H-ESI) sources with stable sensitivity across m/z 40–3,000
• GMP-ready hardware architecture compliant with 21 CFR Part 11 requirements when operated with validated Chromeleon CDS software, including audit trail, electronic signatures, and secure user access controls
• Consistent performance alignment with the Orbitrap Exploris 240 mass spectrometer—enabling direct method portability from development (R&D) to QC without revalidation overhead

Sample Compatibility & Compliance

The Orbitrap Exploris MX supports analysis of diverse biopharmaceutical analytes under both denaturing and native conditions. It routinely characterizes intact mAbs, antibody-drug conjugates (ADCs), bispecific formats, fusion proteins, recombinant enzymes, viral vector capsid proteins, synthetic oligonucleotides (siRNA, antisense, CRISPR guide RNAs), and associated process-related impurities (e.g., deamidation, oxidation, truncations, glycation). The system meets key regulatory expectations outlined in ICH Q5E (comparability), Q5B (protein characterization), and USP <1054> (mass spectrometry in biologics testing). All calibration protocols—including external, one-point, internal lock mass, and EASY-IC—are documented per ISO/IEC 17025 and aligned with GLP/GMP audit readiness requirements. Mass accuracy performance is verified using NIST-traceable standards (e.g., reserpine, angiotensin II, ubiquitin) prior to each analytical run series.

Software & Data Management

The Orbitrap Exploris MX operates exclusively with Thermo Scientific Chromeleon Chromatography Data System (CDS) v7.3 or later, configured in validated GxP mode. Chromeleon provides full 21 CFR Part 11 compliance—including role-based access control, immutable audit trails, electronic signature capture, and data integrity safeguards for raw spectral files (.raw), processed results (.cdf), and report exports. Method templates are preconfigured for common QC assays: peptide mapping (with retention time alignment), intact mass analysis (deconvolution via BioPharma Finder), glycan profiling (using GlycoWorkbench-compatible output), and oligonucleotide purity assessment (with fragment ion annotation). All HRAM datasets retain full centroided and profile-mode spectra for retrospective reprocessing, ensuring future-proofing against evolving regulatory interpretation of mass tolerance thresholds.

Applications

• Batch release testing of therapeutic proteins: confirmation of primary structure, post-translational modifications (PTMs), and higher-order structural integrity
• Comparability studies across manufacturing scale-up, site transfers, or process changes per ICH Q5E guidelines
• Stability-indicating assays tracking oxidative, hydrolytic, and thermal degradation pathways over shelf-life
• Impurity identification and quantification in final drug substance and product—supporting ICH Q3B(R3) reporting thresholds
• Characterization of oligonucleotide therapeutics: sequence verification, phosphorothioate linkage distribution, and n−1/n+1 variant detection
• Support for extractables and leachables (E&L) screening in single-use bioprocessing systems using HRAM-driven formula prediction

FAQ

Is the Orbitrap Exploris MX suitable for regulated QC environments?
Yes. It is designed for GMP-compliant laboratories and supports full 21 CFR Part 11 functionality when deployed with validated Chromeleon CDS software.
What calibration strategy is recommended for daily QC operation?
EASY-IC is the default and preferred method for continuous mass calibration; it eliminates the need for daily external standard injections while maintaining <1 ppm RMS drift over five days.
Can methods developed on an Orbitrap Exploris 240 be directly transferred to the Exploris MX?
Yes. Both platforms share identical mass analyzer geometry, ion optics, and firmware logic—ensuring identical retention time, peak shape, and mass accuracy behavior across instruments.
Does the system support native MS analysis of large protein complexes?
Within its m/z 40–3,000 operating range, the Exploris MX is optimized for subunit-level and intact mAb analysis under denaturing conditions; native MS of megadalton complexes requires higher m/z range instrumentation such as the Orbitrap Eclipse or Astral platforms.
How is data integrity ensured during long-term deployment?
Chromeleon CDS enforces automated checksum validation of raw files, time-stamped audit logs for all user actions, and cryptographic signing of final reports—fully traceable to ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available).